Collectively, the results of the IL-1 receptor blockade and our present findings suggest that impaired myeloid autophagy promotes psoriatic skin inflammation through an effect on IL-1β dysregulation and consequent IL-17-mediated neutrophilic inflammation, thereby supporting a protective role of myeloid autophagy in the pathogenesis of psoriasis. The gene discussed is IL17A; the disease is psoriasis.